Journal for ImmunoTherapy of Cancer (Sep 2017)
Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
- Ashish M. Kamat,
- Joaquim Bellmunt,
- Matthew D. Galsky,
- Badrinath R. Konety,
- Donald L. Lamm,
- David Langham,
- Cheryl T. Lee,
- Matthew I. Milowsky,
- Michael A. O’Donnell,
- Peter H. O’Donnell,
- Daniel P. Petrylak,
- Padmanee Sharma,
- Eila C. Skinner,
- Guru Sonpavde,
- John A. Taylor,
- Prasanth Abraham,
- Jonathan E. Rosenberg
Affiliations
- Ashish M. Kamat
- University of Texas MD Anderson Cancer Center
- Joaquim Bellmunt
- Dana-Farber Cancer Institute
- Matthew D. Galsky
- Tisch Cancer Institute at Mount Sinai Medical Center
- Badrinath R. Konety
- University of Minnesota
- Donald L. Lamm
- BCG Oncology
- David Langham
- Bladder Cancer Advocacy Network, North Carolina Triangle Chapter
- Cheryl T. Lee
- The Ohio State University Wexner Medical Center
- Matthew I. Milowsky
- University of North Carolina
- Michael A. O’Donnell
- University of Iowa
- Peter H. O’Donnell
- University of Chicago
- Daniel P. Petrylak
- Yale Cancer Center
- Padmanee Sharma
- University of Texas MD Anderson Cancer Center
- Eila C. Skinner
- Stanford University
- Guru Sonpavde
- University of Alabama
- John A. Taylor
- University of Kansas Cancer Center
- Prasanth Abraham
- University of Texas MD Anderson Cancer Center
- Jonathan E. Rosenberg
- Memorial Sloan Kettering Cancer Center
- DOI
- https://doi.org/10.1186/s40425-017-0280-z
- Journal volume & issue
-
Vol. 5,
no. 1
pp. 1 – 2
Abstract
No abstracts available.